Individuals with chronic kidney disease, those taking certain medications (PPIs, diuretics, antibiotics), or with gastrointestinal conditions require medical guidance before supplementing
The difference between a result and a risk is rarely the peptide itself
As individuals grow older, their bodies produce higher levels of pro-inflammatory factors compared to the younger population
The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain
This will support the development of therapeutic approaches for diabetes, facilitating the translation of emerging therapies into clinical use
Despite many studies aimed to discover new, selective CBS inhibitors, to date aminooxyacetic acid (AOAA) CBS remains the most commonly used inhibitor of CBS [17]